TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 635.89M | 605.49M | 566.35M | 531.29M | 488.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 635.89M | 605.49M | 566.35M | 531.29M | 488.23M |
| Cost of Revenue | 260.15M | 242.69M | 224.95M | 213.62M | 197.88M |
| Gross Profit | 375.74M | 362.81M | 341.41M | 317.68M | 290.35M |
| SG&A Expenses | 204.53M | 185.17M | 180.63M | 177.27M | 176.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 541.45M | 496.91M | 470.40M | 454.72M | 435.71M |
| Operating Income | 94.44M | 108.58M | 95.95M | 76.58M | 52.52M |
| Income Before Tax | 89.33M | 107.52M | 92.88M | 74.09M | 50.06M |
| Income Tax Expenses | -82.59M | -82.77M | 1.11M | 2.43M | 1.11M |
| Earnings from Continuing Operations | 171.92 | 190.29 | 91.77 | 71.66 | 48.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 171.92M | 190.29M | 91.77M | 71.66M | 48.95M |
| EBIT | 94.44M | 108.58M | 95.95M | 76.58M | 52.52M |
| EBITDA | 125.35M | 134.47M | 120.55M | 100.30M | 74.11M |
| EPS Basic | 5.03 | 5.58 | 2.71 | 2.12 | 1.46 |
| Normalized Basic EPS | 1.64 | 1.98 | 1.71 | 1.37 | 0.93 |
| EPS Diluted | 4.35 | 4.86 | 2.48 | 1.94 | 1.37 |
| Normalized Diluted EPS | 1.39 | 1.66 | 1.45 | 1.17 | 0.83 |
| Average Basic Shares Outstanding | 136.63M | 135.97M | 135.34M | 134.67M | 133.87M |
| Average Diluted Shares Outstanding | 158.43M | 162.15M | 156.43M | 151.37M | 146.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |